NSE: THYROCARE | BSE: 539871

Strong Performer, Getting Expensive

Download real time

1187.50 -5.50 (-0.46%)

New 52W High in past week

96,266 NSE+BSE Volume

NSE 22 Jul, 2025 3:31 PM (IST)

6,293.1

Market Cap

Above industry Median

0.4

Beta 1Year

Very Low volatility

Dividend

Thyrocare Technologies Ltd. has an upcoming dividend of ₹21.00 per share due on 25 Jul 2025 See details

Thyrocare Technologies Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for THYROCARE, BSE:539871 Thyrocare Technologies Ltd.

Thyrocare Technologies Ltd.

25 Apr 2016

1187.50

-0.46%

Thyrocare Technologies Ltd - IPO

Thyrocare Technologies Ltd.

ICICI Securities Limited

Thyrocare Technologies (Thyrocare) is one of the leading pan-India diagnostic chains. The company currently offers 198 tests and 59 profiles of tests to detect a number of disorders. Thyrocare also offers patients and...

Number of FII/FPI investors increased from 80 to 99 in Jun 2025 qtr.

Thyrocare Technologies Ltd.

22 Apr 2016, 12:00AM

1187.50

-0.46%

Thyrocare Technologies Ltd

IPO Subscribe: Thyrocare Technologies Ltd.

AUM Capital

Thyrocare Technologies Limited (TTL) is one of the leading fully automated diagnostic chains and conducts an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases. Under its Aarogyam' brand it provides 16 profiles of tests which offer patients a suite of wellness and preventive health care tests. It operates with a Centralized Processing Laboratory (CPL) in Mumbai for esoteric tests and Regional Processing Laboratory (RPL) in major metros of India and other parts of Asia. The...

Thyrocare Technologies Ltd. has gained 17.59% in the last 1 Month

Thyrocare Technologies Ltd.

22 Apr 2016, 12:00AM

1187.50

-0.46%

Thyrocare Technologies Ltd.

IPO Subscribe: Thyrocare Technologies Ltd.

Ashika Research

The objects of the Offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the sale of 10,744,708 Equity Shares by the Selling Shareholders (up to 10,207,472 Eq Sh by Agalia; up to 180,000 Eq Sh by A. Sundararaju HUF; up to 180,000 Eq Sh by A. Velumani HUF and up to 177,236 Eq Sh by Anand Velumani). The Company will not receive any proceeds of the...

Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.

Is Thyrocare Technologies Ltd. worth buying?

165 Votes:

Buy 76.97%

Sell 12.12%

Hold 10.91%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf